Generation of Tumor-Specific Cytotoxic T Lymphocytes by Stimulation with HPV Type 16 E7 Peptide-Pulsed Dendritic Cells: An Approach to Immunotherapy of Cervical Cancer
Open Access
- 1 September 1999
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 74 (3), 448-455
- https://doi.org/10.1006/gyno.1999.5504
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Combination of Transforming Growth Factor β Antisense and Interleukin-2 Gene Therapy in the Murine Ovarian Teratoma ModelGynecologic Oncology, 1998
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Identification of Peptides for Immunotherapy of Cancer. It is Still Worth the EffortCritical Reviews in Immunology, 1998
- Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigenEuropean Journal of Immunology, 1996
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Induction of peptide‐specific primary cytotoxic T lymphocyte responses from human peripheral bloodEuropean Journal of Immunology, 1995
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993
- Analysis of production, purification, and cytolytic potential of bi‐specific antibodies reactive with ovarian‐carcinoma‐associated antigens and the T‐cell antigen CD3International Journal of Cancer, 1993
- Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell ClonesScience, 1992
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991